Literature DB >> 24830318

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.

Caroline J Tuck1, Jane G Muir, Jacqueline S Barrett, Peter R Gibson.   

Abstract

Irritable bowel syndrome (IBS) was previously left poorly treated despite its high prevalence and cost. Over the past decade, significant research has been conducted providing new dietary strategies for IBS management. The 'low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet' has shown symptom improvement in 68-76% of patients. Randomized, controlled trials have now proven its efficacy. The diet, low in poorly absorbed and fermentable carbohydrates, uses dietary restriction and re-challenge to determine individual tolerance to various short-chain carbohydrates. However there may be potential detrimental effects of the diet in the long term, due to potential changes to the gastrointestinal microbiota. Appropriate dietary education and management of the diet is imperative. Future research should focus on the relevance of changes to the microbiota and ways to liberalize the dietary restrictions.

Entities:  

Keywords:  FODMAP; abdominal pain; carbohydrates; diet therapy; gastrointestinal diseases; irritable bowel syndrome

Mesh:

Substances:

Year:  2014        PMID: 24830318     DOI: 10.1586/17474124.2014.917956

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  30 in total

1.  Constipation in a 40-year-old woman.

Authors:  Himanish Panda; Christopher N Andrews
Journal:  CMAJ       Date:  2015-12-14       Impact factor: 8.262

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Controversies and Recent Developments of the Low-FODMAP Diet.

Authors:  Peta Hill; Jane G Muir; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-01

4.  Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.

Authors:  C J Tuck; K M Taylor; P R Gibson; J S Barrett; J G Muir
Journal:  Am J Gastroenterol       Date:  2017-08-15       Impact factor: 10.864

5.  Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders.

Authors:  Chu K Yao; Caroline J Tuck; Jacqueline S Barrett; Kim Ek Canale; Hamish L Philpott; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

6.  Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.

Authors:  Shinta Mizuno; Tatsuhiro Masaoka; Makoto Naganuma; Taishiro Kishimoto; Momoko Kitazawa; Shunya Kurokawa; Moeko Nakashima; Kozue Takeshita; Wataru Suda; Masaru Mimura; Masahira Hattori; Takanori Kanai
Journal:  Digestion       Date:  2017-06-21       Impact factor: 3.216

Review 7.  Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.

Authors:  Abigail Marsh; Enid M Eslick; Guy D Eslick
Journal:  Eur J Nutr       Date:  2015-05-17       Impact factor: 5.614

Review 8.  Low-residue and low-fiber diets in gastrointestinal disease management.

Authors:  Erika Vanhauwaert; Christophe Matthys; Lies Verdonck; Vicky De Preter
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

Review 9.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17

10.  Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets.

Authors:  Emma P Halmos; Claus T Christophersen; Anthony R Bird; Susan J Shepherd; Jane G Muir; Peter R Gibson
Journal:  Clin Transl Gastroenterol       Date:  2016-04-14       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.